Why Oracle (ORCL) fell 2.88%
Oracle (ORCL) fell 2.88% on September 29, 2026 — Oncology AI in EHR workflow sparks concerns.
What happened
Oracle introduced oncology AI into its EHR (electronic health record) workflow, adding a new AI-native capability to its core enterprise software suite.
Why it moved
The market is discounting the move because oncology AI in EHR lacks visible customer wins or a clear path to material monetization; investors fear feature bloat without revenue lift, pulling back on Oracle's ability to…
Why it matters
Oracle is a crown jewel of enterprise software, but the Hyperscaler Capex cycle has shifted purchasing power toward cloud-native, AI-first platforms—Meta's concurrent enterprise push signals that traditional EHR vendors…
What would break the thesis
If Oracle announces signed deals or revenue-sharing models tied to the oncology AI rollout—especially from major health systems—the narrative flips to a credible new revenue stream, and the stock re-rates higher.